EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.9 | isoniazid | - |
Mycobacterium tuberculosis | |
1.3.1.9 | Trp-Tyr-Trp | structure-based computer modelling approach to design a tripeptide inhibitor. Docking studies indicate that the designed peptide has potency 100 times higher than the best known inhibitor. The results suggest that the designed inhibitor is a suitable lead compound for the development of novel anti-TB drugs | Mycobacterium tuberculosis | |
1.3.1.118 | isoniazid | - |
Mycobacterium tuberculosis | |
1.3.1.118 | Trp-Tyr-Trp | structure-based computer modelling approach to design a tripeptide inhibitor. Docking studies indicate that the designed peptide has potency 100 times higher than the best known inhibitor. The results suggest that the designed inhibitor is a suitable lead compound for the development of novel anti-TB drugs | Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.9 | Mycobacterium tuberculosis | P9WGR1 | - |
- |
1.3.1.9 | Mycobacterium tuberculosis ATCC 25618 | P9WGR1 | - |
- |
1.3.1.118 | Mycobacterium tuberculosis | P9WGR1 | cf. EC 1.3.1.9 | - |
1.3.1.118 | Mycobacterium tuberculosis ATCC 25618 | P9WGR1 | cf. EC 1.3.1.9 | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.1.9 | InhA | - |
Mycobacterium tuberculosis |
1.3.1.118 | InhA | - |
Mycobacterium tuberculosis |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.3.1.9 | metabolism | key enzyme in the biosynthesis of mycolic acids | Mycobacterium tuberculosis |
1.3.1.118 | metabolism | key enzyme in the biosynthesis of mycolic acids | Mycobacterium tuberculosis |